[go: up one dir, main page]

DK2229949T3 - Anvendelse af mælkesyrebakterier til nedsættelse af tandkødsblødning og reduktion af mundbetændelse - Google Patents

Anvendelse af mælkesyrebakterier til nedsættelse af tandkødsblødning og reduktion af mundbetændelse

Info

Publication number
DK2229949T3
DK2229949T3 DK10168703.6T DK10168703T DK2229949T3 DK 2229949 T3 DK2229949 T3 DK 2229949T3 DK 10168703 T DK10168703 T DK 10168703T DK 2229949 T3 DK2229949 T3 DK 2229949T3
Authority
DK
Denmark
Prior art keywords
reduce
lactic acid
acid bacteria
gum bleeding
mouth inflammation
Prior art date
Application number
DK10168703.6T
Other languages
English (en)
Inventor
Bo Moellstam
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Application granted granted Critical
Publication of DK2229949T3 publication Critical patent/DK2229949T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063Periodont
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
DK10168703.6T 2004-06-14 2005-06-14 Anvendelse af mælkesyrebakterier til nedsættelse af tandkødsblødning og reduktion af mundbetændelse DK2229949T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58027904P 2004-06-14 2004-06-14
US11/147,880 US20050281756A1 (en) 2004-06-14 2005-06-08 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
EP05752662A EP1765282B1 (en) 2004-06-14 2005-06-14 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation

Publications (1)

Publication Number Publication Date
DK2229949T3 true DK2229949T3 (da) 2012-02-06

Family

ID=35480800

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10168703.6T DK2229949T3 (da) 2004-06-14 2005-06-14 Anvendelse af mælkesyrebakterier til nedsættelse af tandkødsblødning og reduktion af mundbetændelse
DK05752662.6T DK1765282T3 (da) 2004-06-14 2005-06-14 Anvendelse af mælkesyrebakterierer til nedsættelse af tandkødsblødning og reduktion af mundbetændelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK05752662.6T DK1765282T3 (da) 2004-06-14 2005-06-14 Anvendelse af mælkesyrebakterierer til nedsættelse af tandkødsblødning og reduktion af mundbetændelse

Country Status (19)

Country Link
US (2) US20050281756A1 (da)
EP (2) EP2229949B1 (da)
JP (1) JP2008502714A (da)
KR (1) KR20070018985A (da)
CN (2) CN1980683B (da)
AT (2) ATE537837T1 (da)
AU (2) AU2005251673C1 (da)
CA (1) CA2567867C (da)
DE (1) DE602005023463D1 (da)
DK (2) DK2229949T3 (da)
ES (1) ES2351153T3 (da)
IN (1) IN2006DE07651A (da)
NZ (1) NZ551860A (da)
PL (1) PL1765282T3 (da)
PT (1) PT1765282E (da)
SG (1) SG127405A1 (da)
SI (2) SI2229949T1 (da)
WO (1) WO2005120527A1 (da)
ZA (1) ZA200700211B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2553636T3 (es) 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
CN102115721B (zh) * 2008-05-08 2012-09-26 景岳生物科技股份有限公司 具有抗炎活性的乳杆菌分离株及其用途
DK2437758T3 (da) * 2009-06-03 2014-07-21 Chr Hansen As Bakterie thyA(-) mutanter med forøget vitamin K
US20110014324A1 (en) * 2009-07-10 2011-01-20 Christoffer Lundqvist Product for the storage of freeze-dried lactic acid bacteria mixed with oral rehydration solution
KR101690090B1 (ko) 2009-07-16 2016-12-27 고쿠리츠다이가쿠호진 히로시마다이가쿠 구강내 질환의 예방, 개선 또는 치료제
US20110293710A1 (en) * 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
DE102011116325B4 (de) * 2011-10-14 2016-03-10 orochemie GmbH + Co. KG Neue Milchsäurebakterien und diese enthaltende Zusammensetzungen
AU2012362898B2 (en) * 2011-12-28 2017-11-09 Amgen, Inc. Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
RU2492851C1 (ru) * 2012-08-02 2013-09-20 Сергей Владимирович Кузнецов Способ профилактики и лечения воспаления в ротовой полости после стоматологической хирургической операции
NZ744342A (en) * 2016-01-19 2022-11-25 Symrise Ag Probiotics for use as anti-inflammatory agents in the oral cavity
US20170273334A1 (en) * 2016-03-25 2017-09-28 Zoe Kapp Method of Naturally Decomposing Chewing Gum
EP3351259A1 (en) 2017-01-18 2018-07-25 Symrise AG Probiotics for aggregation with disease-associated species in the oral cavity
US12246078B2 (en) 2017-09-14 2025-03-11 Gerald P. Curatola Oral care formulations and methods for use
WO2020001747A1 (en) 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
KR102720199B1 (ko) 2022-06-30 2024-10-22 대한제당 주식회사 우수한 프로폴리스 내성을 가진 신규 구강 유산균 락토바실러스 루테리 tsb-r7
CN118217218A (zh) * 2024-04-01 2024-06-21 天津大学 预防和治疗牙周炎的益生菌牙膏及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1514469A (en) * 1974-08-01 1978-06-14 Beecham Group Ltd Oral hygiene compositions
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5458875A (en) 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
WO1997022353A1 (en) * 1995-12-21 1997-06-26 Abbott Laboratories Use of lactobacillus reuteri to inhibit cryptosporidiosis in mammals
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US5800813A (en) * 1996-11-12 1998-09-01 Biogaia Biologics Ab Treatment of cryptosporidium infections
KR100266752B1 (ko) * 1997-08-07 2001-03-02 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US20030077814A1 (en) * 1997-08-07 2003-04-24 Oh Jong Suk Novel lactic acid bacteria
KR19990024297A (ko) * 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
WO2002016554A1 (en) * 2000-08-25 2002-02-28 Wakamoto Pharmaceutical Co.,Ltd. Probiotics products containing lactic acid bacterium
WO2003082027A1 (en) * 2002-03-29 2003-10-09 Frente International Co., Ltd. Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
JP2003299480A (ja) * 2002-04-09 2003-10-21 Hiroki Futagawa 虫歯予防用細菌、虫歯予防用食品、虫歯予防用口腔洗浄剤及びヨーグルトの製造方法
US7105336B2 (en) 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
CN1216145C (zh) * 2002-11-07 2005-08-24 上海新立工业微生物科技有限公司 一种嗜热乳酸杆菌以及采用该菌种生产l-乳酸的方法
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries

Also Published As

Publication number Publication date
US20090238774A1 (en) 2009-09-24
US20050281756A1 (en) 2005-12-22
AU2005251673C1 (en) 2010-12-02
CN102851350A (zh) 2013-01-02
SI2229949T1 (sl) 2012-04-30
KR20070018985A (ko) 2007-02-14
CA2567867C (en) 2012-04-10
CN1980683A (zh) 2007-06-13
ES2351153T3 (es) 2011-02-01
PT1765282E (pt) 2010-12-16
AU2010201837A1 (en) 2010-05-27
WO2005120527A1 (en) 2005-12-22
AU2005251673A1 (en) 2005-12-22
PL1765282T3 (pl) 2011-03-31
EP2229949B1 (en) 2011-12-21
CN1980683B (zh) 2012-10-24
ZA200700211B (en) 2008-04-30
HK1101356A1 (en) 2007-10-18
DE602005023463D1 (de) 2010-10-21
IN2006DE07651A (da) 2007-08-17
EP1765282A1 (en) 2007-03-28
CA2567867A1 (en) 2005-12-22
SI1765282T1 (sl) 2010-12-31
CN102851350B (zh) 2015-12-16
AU2005251673B2 (en) 2010-03-04
EP1765282B1 (en) 2010-09-08
DK1765282T3 (da) 2011-01-03
ATE537837T1 (de) 2012-01-15
HK1180372A1 (zh) 2013-10-18
JP2008502714A (ja) 2008-01-31
SG127405A1 (en) 2006-12-29
EP2229949A1 (en) 2010-09-22
NZ551860A (en) 2009-12-24
ATE480248T1 (de) 2010-09-15

Similar Documents

Publication Publication Date Title
DK2229949T3 (da) Anvendelse af mælkesyrebakterier til nedsættelse af tandkødsblødning og reduktion af mundbetændelse
WO2013072932A3 (en) Oral care compositions
NO345046B1 (no) Oral doseringsform
DE60327745D1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
UA102065C2 (en) Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
NO20074895L (no) Isoksazolin derivat og ny fremgangsmate for fremstilling derav
NO20082096L (no) Azaindol-2-karboksamidderivativer
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
CY1111367T1 (el) Νεα παραγωγα της διοσμετινης, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
ATE320203T1 (de) Zahnreinigungsvorrichtung
DE50212760D1 (de) Ermittlung des patientenbezogenen Kariesrisikos
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
UA91541C2 (ru) Бактерицидные макроциклы v, которые содержат амидные группы
PT1749517E (pt) Composição farmacêutica estável compreendendo a forma iv de linezolida
SE0401631D0 (sv) New Composition
MY162652A (en) Novel use of quinolone antibiotics
ATE524488T1 (de) Lysobactinamide
UA89800C2 (en) Acylated nonadepsipeptides used as lysobactin derivatives
MX345779B (es) Composiciones de cuidado bucal.
UA94080C2 (ru) Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
NO20065146L (no) Polymorfer av atorvastatin tert.-butylester og anvendelse derav som mellomprodukter for fremstilling av atorvastatin
ATE455789T1 (de) Substituierte nonadepsipeptide
DE502005006427D1 (de) Substituierte azachinazoline mit antiviraler wirkung